Hansoh Pharmaceutical

GSK heads back to Hansoh, paying $185M upfront for another ADC
Fierce Biotech
Wed, 12/20/23 - 09:46 am
GSK
Hansoh Pharmaceutical
antibody-drug conjugate
In 2nd big ADC deal of the day, GSK inks $2B-plus pact for Hansoh gynecology cancer asset
Fierce Biotech
Sun, 10/22/23 - 06:13 pm
GSK
antibody-drug conjugate
Hansoh Pharmaceutical
Silence Therapeutics, Hansoh partner to develop novel siRNA therapeutics
Pharmaceutical Business Review
Mon, 10/18/21 - 11:06 am
Silence Therapeutics
Hansoh Pharmaceutical
mRNAi
siRNA
drug development
This Chinese pharma filed for an IPO last September. Seven months and a $283M investment later, they are back at the HKEX
Endpoints
Fri, 04/12/19 - 11:44 pm
Hansoh Pharmaceutical
China
IPOs
Hong Kong